Legionella Testing Market Size to Surpass USD 510 million by 2030

The global Legionella Testing market size was estimated at USD 300 million in 2022 and is expected to surpass around USD 510 million by 2030 and poised to grow at a compound annual growth rate (CAGR) of 10.2% during the forecast period 2022 to 2030.

Market growth is driven by the rising geriatric population coupled with increasing prevalence of legionella-related illness, and rising demand for rapid diagnostics.

Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/6864

Report Scope of the Legionella Testing Market

Report Coverage

Details

Market Size

US$ 510 million  by 2030

Growth Rate

CAGR of 10.2% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Test type, application, end user and Region,

 

Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/6864

Driver:  Rapid increase of pneumonia and legionella-related illnesses

According to the European Centre for Disease Prevention and Control (ECDC) (May 2022), Legionnaires’ disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate of 1.9 cases per 100,000 population for the EU/EEA in 2020. France, Germany, Italy, and Spain accounted for 72% of all notified cases. In addition, according to the US CDC (March 2022), the age-standardized average incidence was 0.48 cases/100,000 population during 1992–2002 compared with 2.71/100,000 in 2018.

Opportunity: Legal requirements for water testing

The Environment Protection Agency (EPA) (October 2021) sets legal limits on over 90 contaminants in the US for drinking water. The legal limit for a contaminant reflects the level that protects human health and that water systems can achieve using the best available technology. EPA rules also set water-testing schedules and methods that water systems must follow. In addition, the Safe Drinking Water Act (SDWA) allows individual states to set and enforce their drinking water standards if the standards are at least as stringent as EPA’s national standards.

Restraint: Lack of reimbursement policies

The major factor restraining the growth of the legionella testing market are inadequate reimbursements. According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years. This decline and additional budgetary concerns among healthcare systems will be a major obstacle to implementing novel diagnostic techniques in clinical laboratories.

Challenge: Difficulties in detection

The most common cause of Legionnaire’s disease is Legionella pneumophilia serogroup 1, but it can quickly and easily be identified via the urine antigen test. Legionnaire’s disease can also go undetected once a patient is diagnosed with pneumonia. Best practices dictate that all hospital-acquired pneumonia patients be tested for Legionella in hopes of detecting and preventing a possible outbreak.

The legionella testing market is moderately consolidated. The top players— Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Becton, Dickinson, and Company (US), Roche Diagnostics (Switzerland), and Pall Corporation (Danaher) (US)-in the legionella testing market accounted for a combined majority market share in 2021. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market.

“In 2021, PCR segment accounted for the largest share of the legionella testing market, by test type.”

The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR. The PCR accounted for the largest share of the legionella testing market in 2021, mainly due to its versatility, speed and simplicity.

In 2021, water testing segment accounted for the largest share in the market, by application.

The legionella testing market has been segmented into water testing, IVD testing, and other applications. In 2021, the water testing segment accounted for the largest share of the legionella testing market. Factor such as the changes in lifestyle around the globe and rising elderly population is driving the growth of the market.

“In 2021, water & other industries segment accounted for the largest share in the market, by end user.”

The legionella testing market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end users. In 2021, the water & other industries segment accounted for the largest share of the legionella testing market. The strict water treatment regulations, increasing population and urbanization, and the increased need for new water resources is driving the growth of this segment.

“North America is the largest regional market for legionella testing.”

The global legionella testing market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the legionella testing market. The North American legionella testing market growth can be attributed to the growing elderly population coupled with rising legionella-related illnesses.

Some of the prominent players in the Legionella Testing Market include:

Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Legionella Testing market

By Test Type

  • Culture Methods
  • Urinary Antigen Tests
  • Direct Fluorescent Antibody Tests
  • PCR
    • Motorized Devices
    • Non-Motorized Devices

By Application

  • Water Testing
    • Microbial Culture
    • DFA Stain
    • PCR
  • IVD Testing
    • Blood Culture and Sputum Tests
    • Urinary Antigen Tests
    • DFA Stain
    • PCR
  • Other Applications

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Water & Other Industries
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Legionella Testing industry analysis from 2022 to 2030 to identify the prevailing Legionella Testing industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Legionella Testing industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global Legionella Testing industry trends, key players, market segments, application areas, and market growth strategies.

Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/6864

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

Blog: https://qyresearchmedical.com/

Back to news